
433. How Are Psychedelics and Other Party Drugs Changing Psychiatry?
Freakonomics Radio
00:00
Revolutionizing Mental Health: Ketamine and Psychedelics
This chapter delves into the innovative use of ketamine and other psychedelics in treating depression and PTSD, contrasting their therapeutic potential with traditional antidepressants. The speakers share their insights on safety, efficacy, and the importance of responsible regulation in the context of mental health treatments. Their discussion also addresses the role of government in ensuring product safety amidst the rising popularity of substances like CBD and the complexities of drug approval processes.
Transcript
Play full episode